Thanks.
Thank, Mr. Hinton.
One question I wanted to ask you is about the net benefit test. The net benefit test for 2023, indexed, is just under $2 billion, but most of the small tech start-up companies don't IPO at $2 billion in Canada. They have an enterprise market value of many multiples less than $2 billion.
Do you think that Canada needs to take another look at the net benefit test? We are investing so much here at the university level, and through SR and ED and IRAP, only to see, when it's about to blossom, a U.S. private equity firm come in, take it out and consolidate the market that it has created.
Do we need to look at the net benefit test?